Corteva, Inc. $CTVA Shares Sold by Strs Ohio

Key Points

• Strs Ohio cut its Corteva stake by 9.4% in Q4, selling 31,871 shares and now holds 307,488 shares valued at about $20.61 million.
• Insider Brian Titus sold 8,311 Corteva shares on Feb. 20 at an average $76.55, reducing his position by 50.67%; company insiders own about 0.15% of the stock.
• Corteva reported quarterly EPS of $0.22 (in line) but revenue of $3.91 billion missed estimates, set FY2026 guidance of $3.45–$3.70 EPS, and announced a $0.18 quarterly dividend (0.9% yield).

Strs Ohio lowered its stake in shares of Corteva, Inc. (NYSE:CTVA - Free Report) by 9.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 307,488 shares of the company's stock after selling 31,871 shares during the quarter. Strs Ohio's holdings in Corteva were worth $20,611,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Activest Wealth Management raised its holdings in Corteva by 118.3% during the third quarter. Activest Wealth Management now owns 369 shares of the company's stock worth $25,000 after purchasing an additional 200 shares in the last quarter. JPL Wealth Management LLC acquired a new stake in Corteva during the third quarter worth approximately $25,000. True Wealth Design LLC raised its holdings in Corteva by 209.5% during the third quarter. True Wealth Design LLC now owns 390 shares of the company's stock worth $26,000 after purchasing an additional 264 shares in the last quarter. Redmont Wealth Advisors LLC acquired a new stake in Corteva during the third quarter worth approximately $29,000. Finally, Jackson Grant Investment Advisers Inc. raised its holdings in Corteva by 90.6% during the third quarter. Jackson Grant Investment Advisers Inc. now owns 448 shares of the company's stock worth $30,000 after purchasing an additional 213 shares in the last quarter. Institutional investors and hedge funds own 81.54% of the company's stock.

Insiders Place Their Bets

In related news, insider Brian Titus sold 8,311 shares of Corteva stock in a transaction on Friday, February 20th. The shares were sold at an average price of $76.55, for a total value of $636,207.05. Following the transaction, the insider directly owned 8,090 shares in the company, valued at $619,289.50. This trade represents a 50.67% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. 0.15% of the stock is currently owned by company insiders.

Corteva Stock Performance

Shares of CTVA stock opened at $80.97 on Monday. The stock has a market capitalization of $54.36 billion, a PE ratio of 51.24, a price-to-earnings-growth ratio of 2.77 and a beta of 0.59. Corteva, Inc. has a 52-week low of $60.53 and a 52-week high of $85.63. The stock's 50-day moving average price is $80.39 and its 200 day moving average price is $72.18. The company has a quick ratio of 0.96, a current ratio of 1.43 and a debt-to-equity ratio of 0.07.

Corteva (NYSE:CTVA - Get Free Report) last issued its quarterly earnings results on Tuesday, February 3rd. The company reported $0.22 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.22. Corteva had a return on equity of 9.06% and a net margin of 6.29%.The firm had revenue of $3.91 billion for the quarter, compared to analysts' expectations of $4.23 billion. During the same quarter in the previous year, the firm posted $0.32 EPS. The firm's revenue for the quarter was down 1.7% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. As a group, equities research analysts forecast that Corteva, Inc. will post 3.62 EPS for the current year.

Corteva Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, June 15th. Investors of record on Monday, June 1st will be given a $0.18 dividend. This represents a $0.72 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date is Monday, June 1st. Corteva's dividend payout ratio (DPR) is 45.57%.

Analyst Ratings Changes

A number of research firms have weighed in on CTVA. Berenberg Bank raised their price objective on shares of Corteva from $68.00 to $78.00 and gave the stock a "hold" rating in a report on Thursday, March 26th. Wolfe Research raised their target price on shares of Corteva from $81.00 to $86.00 and gave the stock an "outperform" rating in a research report on Thursday, February 5th. Weiss Ratings restated a "hold (c)" rating on shares of Corteva in a research report on Wednesday, April 22nd. Deutsche Bank Aktiengesellschaft raised their target price on shares of Corteva from $85.00 to $90.00 and gave the stock a "buy" rating in a research report on Thursday, February 5th. Finally, Citigroup raised their target price on shares of Corteva from $74.00 to $80.00 and gave the stock a "neutral" rating in a research report on Thursday, February 5th. Fourteen investment analysts have rated the stock with a Buy rating and nine have given a Hold rating to the stock. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus price target of $86.38.

Corteva Company Profile

Corteva, Inc NYSE: CTVA is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva's operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.

Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.